{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T11:02:53Z","timestamp":1772017373342,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye and Vis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study aimed to compare the complication rates of epithelium-off corneal cross-linking (epi-off CXL) performed in an office-based setting with those of epi-off CXL performed in an operating room.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective cohort study, comprising 501 consecutive epi-off CXL procedures, performed in a non-sterile procedure room without laminar flow ventilation at the ELZA Institute in Zurich, Switzerland, between November 2015 and October 2021, was conducted.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>No cases of postoperative infectious keratitis were observed, while sterile infiltrates occurred in 10 out of 501 (2.00%) patients, all of whom responded well to topical steroid therapy. Delayed epithelialization (&gt;\u20097\u00a0days) occurred in 14 out of 501 (2.79%) patients. No other adverse events were noted.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Office-based epi-off CXL does not appear to be associated with an increased risk of complications when compared to operating room settings.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40662-023-00354-1","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:02:09Z","timestamp":1693526529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Rates of infectious keratitis and other ocular surface adverse events in corneal cross-linking for keratoconus and corneal ectasias performed in an office-based setting: a retrospective cohort study"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8935-4558","authenticated-orcid":false,"given":"Farhad","family":"Hafezi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio A.","family":"Torres-Netto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard","family":"Kollros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan-Ji","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikki","family":"Hafezi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cosimo","family":"Mazzotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Enes","family":"Aydemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Hillen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,1]]},"reference":[{"issue":"6","key":"354_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.survophthal.2015.04.002","volume":"60","author":"JB Randleman","year":"2015","unstructured":"Randleman JB, Khandelwal SS, Hafezi F. Corneal cross-linking. Surv Ophthalmol. 2015;60(6):509\u201323.","journal-title":"Surv Ophthalmol"},{"issue":"10","key":"354_CR2","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1097\/ICO.0000000000001707","volume":"37","author":"MW Belin","year":"2018","unstructured":"Belin MW, Lim L, Rajpal RK, Hafezi F, Gomes JAP, Cochener B. Corneal cross-linking: current USA status: report from the cornea society. Cornea. 2018;37(10):1218\u201325.","journal-title":"Cornea"},{"issue":"2","key":"354_CR3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3928\/1081597X-20201123-02","volume":"37","author":"F Hafezi","year":"2021","unstructured":"Hafezi F, Richoz O, Torres-Netto EA, Hillen M, Hafezi NL. Corneal cross-linking at the slit lamp. J Refract Surg. 2021;37(2):78\u201382.","journal-title":"J Refract Surg"},{"key":"354_CR4","first-page":"15","volume":"80","author":"V Kumar","year":"2004","unstructured":"Kumar V, Lockerbie O, Keil SD, Ruane PH, Platz MS, Martin CB, et al. Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level. Photochem Photobiol. 2004;80:15\u201321.","journal-title":"Photochem Photobiol"},{"key":"354_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40662-016-0042-x","volume":"3","author":"D Tabibian","year":"2016","unstructured":"Tabibian D, Mazzotta C, Hafezi F. PACK-CXL: corneal cross-linking in infectious keratitis. Eye Vis (Lond). 2016;3:11.","journal-title":"Eye Vis (Lond)"},{"issue":"1","key":"354_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40662-021-00272-0","volume":"9","author":"F Hafezi","year":"2022","unstructured":"Hafezi F, Hosny M, Shetty R, Knyazer B, Chen S, Wang Q, et al. PACK-CXL vs. antimicrobial therapy for bacterial, fungal, and mixed infectious keratitis: a prospective randomized phase 3 trial. Eye Vis (Lond). 2022;9(1):2.","journal-title":"Eye Vis (Lond)."},{"issue":"4","key":"354_CR7","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3928\/1081597X-20200226-02","volume":"36","author":"B Knyazer","year":"2020","unstructured":"Knyazer B, Krakauer Y, Tailakh MA, Achiron A, Hecht I, Lifshitz T, et al. Accelerated corneal cross-linking as an adjunct therapy in the management of presumed bacterial keratitis: a cohort study. J Refract Surg. 2020;36(4):258\u201364.","journal-title":"J Refract Surg"},{"issue":"4","key":"354_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2017.6233","volume":"153","author":"CP Childers","year":"2018","unstructured":"Childers CP, Maggard-Gibbons M. Understanding costs of care in the operating room. JAMA Surg. 2018;153(4):e176233.","journal-title":"JAMA Surg"},{"issue":"10","key":"354_CR9","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1001\/jamaophthalmol.2021.3096","volume":"139","author":"T Li","year":"2021","unstructured":"Li T, Sun J, Min J, Zhou S, Zhu X, Jia H, et al. Safety of receiving anti-vascular endothelial growth factor intravitreal injection in office-based vs operating room settings: a meta-analysis. JAMA Ophthalmol. 2021;139(10):1080\u20138.","journal-title":"JAMA Ophthalmol"},{"issue":"9","key":"354_CR10","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1097\/IAE.0000000000000321","volume":"34","author":"A Porteous","year":"2014","unstructured":"Porteous A, Vemala R, Field J, Islam N. Equally low rates of endophthalmitis after intravitreal injections. Retina. 2014;34(9):e26\u20137.","journal-title":"Retina"},{"issue":"1","key":"354_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/IAE.0000000000000008","volume":"34","author":"H Tabandeh","year":"2014","unstructured":"Tabandeh H, Boscia F, Sborgia A, Cirac\u00ec L, Dayani P, Mariotti C, et al. Endophthalmitis associated with intravitreal injections: office-based setting and operating room setting. Retina. 2014;34(1):18\u201323.","journal-title":"Retina"},{"issue":"5","key":"354_CR12","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.ajo.2007.12.036","volume":"145","author":"S Pilli","year":"2008","unstructured":"Pilli S, Kotsolis A, Spaide RF, Slakter J, Freund KB, Sorenson J, et al. Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting. Am J Ophthalmol. 2008;145(5):879\u201382.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"354_CR13","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ophtha.2015.12.020","volume":"123","author":"T Ianchulev","year":"2016","unstructured":"Ianchulev T, Litoff D, Ellinger D, Stiverson K, Packer M. Office-based cataract surgery: population health outcomes study of more than 21 000 cases in the United States. Ophthalmology. 2016;123(4):723\u20138.","journal-title":"Ophthalmology"},{"issue":"14","key":"354_CR14","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.3390\/jcm11144109","volume":"11","author":"F Hafezi","year":"2022","unstructured":"Hafezi F, Hillen M, Kollros L, Tan J, Awwad ST. A new postoperative regimen after CXL and PRK using topical NSAID and steroids on the open ocular surface. J Clin Med. 2022;11(14):4109.","journal-title":"J Clin Med"},{"issue":"8","key":"354_CR15","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.jcrs.2009.03.035","volume":"35","author":"T Koller","year":"2009","unstructured":"Koller T, Mrochen M, Seiler T. Complication and failure rates after corneal crosslinking. J Cataract Refract Surg. 2009;35(8):1358\u201362.","journal-title":"J Cataract Refract Surg"},{"issue":"6","key":"354_CR16","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.jcrs.2009.01.036","volume":"35","author":"JJ P\u00e9rez-Santonja","year":"2009","unstructured":"P\u00e9rez-Santonja JJ, Artola A, Javaloy J, Ali\u00f3 JL, Abad JL. Microbial keratitis after corneal collagen crosslinking. J Cataract Refract Surg. 2009;35(6):1138\u201340.","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"354_CR17","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jcrs.2008.09.029","volume":"35","author":"M Pollhammer","year":"2009","unstructured":"Pollhammer M, Cursiefen C. Bacterial keratitis early after corneal crosslinking with riboflavin and ultraviolet-A. J Cataract Refract Surg. 2009;35(3):588\u20139.","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"354_CR18","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jcrs.2009.08.041","volume":"36","author":"N Sharma","year":"2010","unstructured":"Sharma N, Maharana P, Singh G, Titiyal JS. Pseudomonas keratitis after collagen crosslinking for keratoconus: case report and review of literature. J Cataract Refract Surg. 2010;36(3):517\u201320.","journal-title":"J Cataract Refract Surg"},{"key":"354_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2020.100616","volume":"17","author":"S McGirr","year":"2020","unstructured":"McGirr S, Andersen D, Halgren J. Alternaria keratitis after corneal crosslinking. Am J Ophthalmol Case Rep. 2020;17:100616.","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"11","key":"354_CR20","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.jcrs.2007.06.036","volume":"33","author":"GD Kymionis","year":"2007","unstructured":"Kymionis GD, Portaliou DM, Bouzoukis DI, Suh LH, Pallikaris AI, Markomanolakis M, et al. Herpetic keratitis with iritis after corneal crosslinking with riboflavin and ultraviolet A for keratoconus. J Cataract Refract Surg. 2007;33(11):1982\u20134.","journal-title":"J Cataract Refract Surg"},{"key":"354_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/340509","volume":"2014","author":"R Shetty","year":"2014","unstructured":"Shetty R, Kaweri L, Nuijts RM, Nagaraja H, Arora V, Kumar RS. Profile of microbial keratitis after corneal collagen cross-linking. Biomed Res Int. 2014;2014:340509.","journal-title":"Biomed Res Int"},{"issue":"1","key":"354_CR22","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10792-021-02019-1","volume":"42","author":"S Serrao","year":"2022","unstructured":"Serrao S, Lombardo G, Lombardo M. Adverse events after riboflavin\/UV-A corneal cross-linking: a literature review. Int Ophthalmol. 2022;42(1):337\u201348.","journal-title":"Int Ophthalmol"},{"key":"354_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/869015","volume":"2011","author":"S Dhawan","year":"2011","unstructured":"Dhawan S, Rao K, Natrajan S. Complications of corneal collagen cross-linking. J Ophthalmol. 2011;2011:869015.","journal-title":"J Ophthalmol"},{"issue":"9","key":"354_CR24","first-page":"S819","volume":"25","author":"C Koppen","year":"2009","unstructured":"Koppen C, Vryghem JC, Gobin L, Tassignon MJ. Keratitis and corneal scarring after UVA\/riboflavin cross-linking for keratoconus. J Refract Surg. 2009;25(9):S819\u201323.","journal-title":"J Refract Surg"},{"key":"354_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ajo.2020.12.011","volume":"224","author":"F Hafezi","year":"2021","unstructured":"Hafezi F, Kling S, Gilardoni F, Hafezi N, Hillen M, Abrishamchi R, et al. Individualized corneal cross-linking with riboflavin and UV-A in ultrathin corneas: the Sub400 Protocol. Am J Ophthalmol. 2021;224:133\u201342.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"354_CR26","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S0002-9394(02)02220-1","volume":"135","author":"G Wollensak","year":"2003","unstructured":"Wollensak G, Spoerl E, Seiler T. Riboflavin\/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135(5):620\u20137.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"354_CR27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3928\/1081597X-20161219-03","volume":"33","author":"B Salmon","year":"2017","unstructured":"Salmon B, Richoz O, Tabibian D, Kling S, Wuarin R, Hafezi F. CXL at the slit lamp: no clinically relevant changes in corneal riboflavin distribution during upright UV irradiation. J Refract Surg. 2017;33(4):281.","journal-title":"J Refract Surg"},{"issue":"19","key":"354_CR28","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.3390\/jcm11195873","volume":"11","author":"F Hafezi","year":"2022","unstructured":"Hafezi F, Lu NJ, Assaf JF, Hafezi NL, Koppen C, Vinciguerra R, et al. Demarcation line depth in epithelium-off corneal cross-linking performed at the slit lamp. J Clin Med. 2022;11(19):5873.","journal-title":"J Clin Med"},{"issue":"1","key":"354_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00417-011-1754-1","volume":"250","author":"K Makdoumi","year":"2012","unstructured":"Makdoumi K, Mortensen J, Sorkhabi O, Malmvall BE, Crafoord S. UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study. Graefes Arch Clin Exp Ophthalmol. 2012;250(1):95\u2013102.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"354_CR30","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3928\/1081597X-20190128-01","volume":"35","author":"P Vinciguerra","year":"2019","unstructured":"Vinciguerra P, Rosetta P, Legrottaglie EF, Morenghi E, Mazzotta C, Kaye SB, et al. Iontophoresis CXL with and without epithelial debridement versus standard CXL: 2-year clinical results of a prospective clinical study. J Refract Surg. 2019;35(3):184\u201390.","journal-title":"J Refract Surg"}],"updated-by":[{"DOI":"10.1186\/s40662-023-00360-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000}}],"container-title":["Eye and Vision"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40662-023-00354-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40662-023-00354-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40662-023-00354-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T21:52:04Z","timestamp":1700430724000},"score":1,"resource":{"primary":{"URL":"https:\/\/eandv.biomedcentral.com\/articles\/10.1186\/s40662-023-00354-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["354"],"URL":"https:\/\/doi.org\/10.1186\/s40662-023-00354-1","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s40662-023-00360-3","asserted-by":"object"}]},"ISSN":["2326-0254"],"issn-type":[{"value":"2326-0254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]},"assertion":[{"value":"6 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s40662-023-00360-3","URL":"https:\/\/doi.org\/10.1186\/s40662-023-00360-3","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were performed in accordance with relevant guidelines. The ethics committee of Canton Zurich (Zurich Kantonale Ethikkommission, BASEC-Nr. Req-2021-01121) waived the need for written informed consent and ethical approval for the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NH is CEO of EMAGine AG, a company producing a CXL device. FH holds a patent on a UV light source (PCT\/CH 2012\/000090) and is CSO of EMAGine AG. FH is an editorial board member of Eye and Vision. The other authors have no proprietary or commercial interest in any of the materials discussed in this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}